Zhao T - Search Results

1

[Effect of Selenious Yeast Tablets on the Thyroglobulin Antibody Level in ThyroglobulinAntibody-positive Patients with Differentiated Thyroid Cancer].

Cong H, Li H, Liang J, Yang K, Zhao T, Qiu WS, Lin YS. Cong H, et al. Among authors: zhao t. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Oct;37(5):591-5. doi: 10.3881/j.issn.1000-503X.2015.05.017. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015. PMID: 26564513 Chinese.

2

Relationship between Variation of Pre-ablation Stimulated Thyroglobulin and Distant Metastasis in Patients with Differentiated Thyroid Cancer.

Zhao T, Liang J, Li TJ, Li CX, Hui C, Yang K, Li F, Lin YS. Zhao T, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Jun;37(3):315-9. doi: 10.3881/j.issn.1000-503X.2015.03.013. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015. PMID: 26149144

3

Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.

Zhao T, Liang J, Guo Z, Li J, Lin Y. Zhao T, et al. Endocrine. 2016 Jul;53(1):166-73. doi: 10.1007/s12020-015-0842-0. Epub 2016 Jan 18. Endocrine. 2016. PMID: 26782372

4

Preablative Stimulated Thyroglobulin Correlates to New Therapy Response System in Differentiated Thyroid Cancer.

Yang X, Liang J, Li T, Zhao T, Lin Y. Yang X, et al. Among authors: zhao t. J Clin Endocrinol Metab. 2016 Mar;101(3):1307-13. doi: 10.1210/jc.2015-4016. Epub 2016 Jan 20. J Clin Endocrinol Metab. 2016. PMID: 26789779

5

Value of serial preablative thyroglobulin measurements: can we address the impact of thyroid remnants?

Zhao T, Liang J, Li T, Guo Z, Vinjamuri S, Lin Y. Zhao T, et al. Nucl Med Commun. 2016 Jun;37(6):632-9. doi: 10.1097/MNM.0000000000000485. Nucl Med Commun. 2016. PMID: 26829063

6

Response to (131)I Therapy in Non-metastatic Differentiated Thyroid CancerPatients with Preablative Stimulated Thyroglobulin above 10 ng/ml.

Hou M, Zhao T, Yang X, Li J, Li H, Lin YS. Hou M, et al. Among authors: zhao t. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Feb;38(1):83-7. doi: 10.3881/j.issn.1000-503X.2016.01.015. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 26956862

7

Clinical Outcome of (131)I Therapy in Differentiated Thyroid Cancer with Preablative Thyroglobulin below 10 ng/ml.

Liu XF, Li J, Zhao T, Hou M, Li H, Liang J, Lin YS. Liu XF, et al. Among authors: zhao t. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Feb;38(1):88-92. doi: 10.3881/j.issn.1000-503X.2016.01.016. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 26956863

8

Clinical Outcome of Radioiodine Therapy in Low-intermediate Risk Papillary Thyroid Carcinoma with BRAF(V600E) Mutation.

Li J, Yang T, Zhao T, Liang J, Lin YS. Li J, et al. Among authors: zhao t. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Jun 10;38(3):346-50. doi: 10.3881/j.issn.1000-503X.2016.03.019. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 27544995

9

Effect of Lymph Node Metastasis on Change of Positive Thyroglobulin Antibody in Differentiated Thyroid Carcinoma after Initial Treatment.

Zhang T, Song LP, Zhao T, Gao W, Lin YS. Zhang T, et al. Among authors: zhao t. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Aug 20;39(4):539-543. doi: 10.3881/j.issn.1000-503X.2017.04.013. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017. PMID: 28877833 English.

10

Suppressed thyroglobulin performs better than stimulated thyroglobulin in defining an excellent response in patients with differentiated thyroid cancer.

Hu HY, Liang J, Zhang T, Zhao T, Lin YS. Hu HY, et al. Among authors: zhao t. Nucl Med Commun. 2018 Mar;39(3):247-251. doi: 10.1097/MNM.0000000000000796. Nucl Med Commun. 2018. PMID: 29438217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,667 results

Search Page

Filters